NEUE vs. BHG, TOI, XAIR, INAB, ALGS, RMTI, CLNN, BLRX, NTRB, and ZEPP
Should you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include Bright Health Group (BHG), Oncology Institute (TOI), Beyond Air (XAIR), IN8bio (INAB), Aligos Therapeutics (ALGS), Rockwell Medical (RMTI), Clene (CLNN), BioLineRx (BLRX), Nutriband (NTRB), and Zepp Health (ZEPP). These companies are all part of the "medical" sector.
NeueHealth (NYSE:NEUE) and Bright Health Group (NYSE:BHG) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk, community ranking and dividends.
NeueHealth has higher earnings, but lower revenue than Bright Health Group. NeueHealth is trading at a lower price-to-earnings ratio than Bright Health Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, NeueHealth had 4 more articles in the media than Bright Health Group. MarketBeat recorded 5 mentions for NeueHealth and 1 mentions for Bright Health Group. Bright Health Group's average media sentiment score of 0.10 beat NeueHealth's score of -0.29 indicating that Bright Health Group is being referred to more favorably in the news media.
NeueHealth has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Bright Health Group has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.
Bright Health Group has a net margin of -85.40% compared to NeueHealth's net margin of -89.78%. Bright Health Group's return on equity of 0.00% beat NeueHealth's return on equity.
Bright Health Group received 15 more outperform votes than NeueHealth when rated by MarketBeat users. Likewise, 30.00% of users gave Bright Health Group an outperform vote while only 0.00% of users gave NeueHealth an outperform vote.
63.9% of NeueHealth shares are held by institutional investors. 64.3% of NeueHealth shares are held by insiders. Comparatively, 58.4% of Bright Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
NeueHealth currently has a consensus target price of $8.00, suggesting a potential upside of 33.56%. Bright Health Group has a consensus target price of $13.00, suggesting a potential upside of 117.03%. Given Bright Health Group's higher possible upside, analysts plainly believe Bright Health Group is more favorable than NeueHealth.
Summary
Bright Health Group beats NeueHealth on 9 of the 17 factors compared between the two stocks.
Get NeueHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeueHealth Competitors List
Related Companies and Tools
